Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

NCT00752635 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Norgestimate-ethinyl estradiol; Cyproterone acetate-ethinyl estradiol

Sponsor

Johnson & Johnson Taiwan Ltd